data monitoring committees

Monitor Says Celgene Cancer Drug Meets Late-Stage Goals

Monitor says Celgene cancer drug meets late-stage goals

Filed under: drug treatment news

The study's data safety monitoring board also determined that the pomalidomide drug, given in combination with a low dose of existing treatment dexamethasone, was superior to a high dose of the existing treatment in improving overall survival… Continue reading